Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dalmases

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 28, 2007
mTOR signalling in human cancerJ Albanell, A Dalmases, A Rovira, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 3, 2007
Pharmacodynamics: biological activity of targeted therapies in clinical trialsF Rojo, A Dalmases, J M Corominas, et al.
British Journal of Cancer|March 18, 2010
Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patientsC Montagut, M Iglesias, M Arumi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2017
Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patientsJ Vidal, L Muinelo, A Dalmases, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 28, 2007
mTOR signalling in human cancerJ Albanell, A Dalmases, A Rovira, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 3, 2007
Pharmacodynamics: biological activity of targeted therapies in clinical trialsF Rojo, A Dalmases, J M Corominas, et al.
British Journal of Cancer|March 18, 2010
Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patientsC Montagut, M Iglesias, M Arumi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2017
Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patientsJ Vidal, L Muinelo, A Dalmases, et al.
Pageof 1